era 223 and implications for clinical practice
Published 5 years ago • 101 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
8:45
era 223 study | concerns for using radium-223 and abiraterone
-
6:25
dr. george discusses radium-223 for patients with mcrpc part i
-
13:09
radium-223 alone and with other agents for prostate cancer
-
10:33
ep. 12: what is radium 223’s role in mcrpc management?
-
1:08
dr. a. oliver sartor on the mechanism of action of radium-223
-
11:13
6.6 - cancer: adaptive chemotherapy
-
1:12:41
urowebinar: prostate cancer imaging: when and how to use it?
-
3:49
prostate cancer - radium 223 treatment at uhbw
-
5:16
significance of the era 223 trial in mcrpc
-
9:48
radium-223 in combination therapy for mcrpc
-
4:58
administering radium-223 and integrating clinic trials
-
6:51
radium-223: treatment considerations
-
9:54
radium-223 for treatment of prostate cancer
-
10:09
radium-223 in metastatic crpc
-
0:46
dr. morris on mechanism of action for radium-223
-
6:38
the era 223/peace iii trials & the future of mcrpc treatment
-
4:42
dr. george discusses radium-223 for patients with mcrpc part ii
-
3:56
bone-targeted therapy for prostate cancer: radium-223
-
1:10
dr. dreicer on challenges of radium-223 in prostate cancer
-
15:05
radium-223 in bone-metastatic castration-resistant prostate cancer
-
1:44
dr. mckay on the real-world utilization of radium-223 in mcrpc
-
0:53
dr. higano on combinations with radium-223 for prostate cancer